As a public policy, the key to national pharmacare will be integration, as evidenced by other countries with a universal health care system. The reality is that Canada doesn't have one national health care system, but a patchwork of different private-public mixes.

Some of the requirements make no sense. To get OHIP+ coverage for Keppra, a favoured choice to treat epilepsy, for example, patients now have to have tried and failed older, cheaper anti-epilepsy drugs. That's just not practical for many children.